![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion” or the “Company”), a company dedicated to ending obesity, today announced that it will report financial results for the second quarter 2024 on...
Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion” or the “Company”), a company dedicated to ending obesity, today announced the pricing of an underwritten public offering of 14,406,508 shares...
Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion” or the “Company”), a company dedicated to ending obesity, today announced that it has launched an underwritten public offering of up to $20...
Patients gained an average of 5.6% in lean body mass during the Allurion Program Separate studies of patients on GLP-1 therapy report an average lean mass loss of 11%1 Allurion Technologies, Inc...
New data show 22.1% weight loss at one year with consecutive Allurion Balloons, approaching weight loss surgery outcomes Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending...
Allurion Technologies, Inc. (NYSE:ALUR), a company dedicated to ending obesity, today announced the appointment of Ojas A. Buch as its new Chief Operating Officer. Effective June 3, 2024, Ojas...
Company also announces first commercial agreements for the Virtual Care Suite in the United States Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced...
Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced that it will be participating in two upcoming investor conferences: Jefferies Global Healthcare...
New data demonstrate significant fat mass loss while preserving lean mass Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced three scientific...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | -0.11 | -0.912863070539 | 12.05 | 12.05 | 12.05 | 168400 | 12.05 | CS |
26 | -0.11 | -0.912863070539 | 12.05 | 12.05 | 12.05 | 168400 | 12.05 | CS |
52 | -0.11 | -0.912863070539 | 12.05 | 12.05 | 12.05 | 168400 | 12.05 | CS |
156 | -0.11 | -0.912863070539 | 12.05 | 12.05 | 12.05 | 168400 | 12.05 | CS |
260 | -0.11 | -0.912863070539 | 12.05 | 12.05 | 12.05 | 168400 | 12.05 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions